SCHEMBL15325653

SCHEMBL15325653

COC(=O)/C=C/c1c[nH]c2ccc(OCc3ccccc3)cc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
MAPT P10636 2/20 0.58
NPC1 O15118 1/20 0.58
ALDH1A1 P00352 1/20 0.58
RAB9A P51151 1/20 0.58
GAA P10253 1/20 0.57
GPR55 Q9Y2T6 1/20 0.57
MAP3K7 O43318 1/20 0.56
TAB1 Q15750 1/20 0.56
LTA4H P09960 5/20 0.53
PLA2G2A P14555 5/20 0.53
HSP90AA1 P07900 1/20 0.53
HSP90AB1 P08238 1/20 0.53
TRPM8 Q7Z2W7 3/20 0.52
ACHE P22303 1/20 0.51
HDAC8 Q9BY41 2/20 0.51
HDAC3 O15379 1/20 0.51
HDAC4 P56524 1/20 0.51
HDAC1 Q13547 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15323122 1.00 MEN1 (0.58) MEN1KMT2AMAPTNPC1ALDH1A1
SCHEMBL16589532 0.91 ALDH1A1 (0.56) MEN1KMT2AMAPTNPC1ALDH1A1
SCHEMBL10501064 0.90 MEN1 (0.59) MEN1KMT2AMAPTNPC1ALDH1A1
SCHEMBL10501049 0.90 MEN1 (0.59) MEN1KMT2AMAPTNPC1ALDH1A1
SCHEMBL12909375 0.83 MEN1 (0.58) MEN1KMT2AMAPTNPC1ALDH1A1
SCHEMBL3019508 0.82 MEN1 (0.70) MEN1KMT2AMAPTNPC1ALDH1A1
SCHEMBL3019510 0.82 MEN1 (0.70) MEN1KMT2AMAPTNPC1ALDH1A1
SCHEMBL7835457 0.82 MEN1 (0.64) MEN1KMT2AMAPTNPC1ALDH1A1
SCHEMBL7835462 0.82 MEN1 (0.64) MEN1KMT2AMAPTNPC1ALDH1A1
SCHEMBL13724460 0.81 ALDH1A1 (0.62) MEN1KMT2AMAPTNPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9499484-B2 Indole, indoline derivatives, compositions comprising them and uses thereof YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) 2016-11-22 US disclosed
US-9499484-B2 Indole, indoline derivatives, compositions comprising them and uses thereof YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) 2016-11-22 US disclosed
US-20150087617-A1 INDOLE, INDOLINE DERIVATIVES, COMPOSITIONS COMPRISING THEM AND USES THEREOF YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) 2015-03-26 US disclosed
US-20150087617-A1 INDOLE, INDOLINE DERIVATIVES, COMPOSITIONS COMPRISING THEM AND USES THEREOF YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) 2015-03-26 US disclosed
WO-2013150529-A2 INDOLE, INDOLINE DERIVATIVES, COMPOSITIONS COMPRISING THEM AND USES THEREOF YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) 2013-10-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150087617-A1 INDOLE, INDOLINE DERIVATIVES, COMPOSITIONS COMPRISING THEM AND USES THEREOF IDO1, INMT, IDO2 MEN1 2212/4885KMT2A 425/4885MAPT 48/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.